Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Want to see HK:2096 full AI Analyst Report?
Comparison Results
Simcere Pharmaceutical Group Limited
HK$13.79
HK$30.50B
9.28
30.99%
3 Buy
0 Hold
0 Sell
Strong Buy
InnoCare Pharma Ltd.
HK$11.75
HK$20.18B
50.10
36.23%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$41.63B
-256.36
58.13%
3 Buy
0 Hold
0 Sell
Strong Buy
Everest Medicines Ltd.
HK$51.50
HK$11.94B
―
-31.59%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$40.87B
―
102.97%
6 Buy
0 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$50.90
HK$15.65B
-6.78
-16.15%
2 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:2096
Simcere Pharmaceutical Group Limited
11.75
3.27
38.56%
HK:9969
InnoCare Pharma Ltd.
13.50
3.95
41.36%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.30
10.36
69.34%
HK:1952
Everest Medicines Ltd.
33.76
-14.54
-30.10%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
75.20
38.60
105.46%
HK:6855
Ascentage Pharma Group International
42.26
-4.14
-8.92%